Table 1 Baseline characteristics of HGU patients
Characteristics | Non-elderly (n = 390) | Elderly (n = 192) | p value |
|---|---|---|---|
Patient number | 390 | 192 | |
Sex (male/female) | 309/81 | 116/76 | < 0.001 |
Age (mean ± SD) | 59.2 ± 11.3 | 81.8 ± 5.0 | < 0.001 |
Weekend hospitalization | 90 (23%) | 38 (20%) | 0.43 |
Location of HGU | |||
Fundus | 13 (3%) | 5 (2%) | 0.8 |
Gastric body | 127 (33%) | 90 (47%) | 0.001 |
Gastric angle | 72 (19%) | 30 (16%) | 0.47 |
Antral zone | 51 (13%) | 30 (16%) | 0.48 |
Anterior wall of duodenal bulb | 97 (25%) | 26 (14%) | 0.0024 |
Posterior wall of duodenal bulb | 30 (8%) | 12 (6%) | 0.64 |
Second part of duodenum | 6 (2%) | 5 (3%) | 0.52 |
Endoscopic features | |||
Forrest classifications | |||
Ia | 32 (8%) | 17 (9%) | 0.92 |
Ib | 65 (17%) | 39 (20%) | 0.34 |
IIa | 145 (37%) | 52 (27%) | 0.02 |
IIb | 38 (10%) | 19 (10%) | 1 |
IIc | 27 (7%) | 23 (12%) | 0.059 |
III | 83 (21%) | 42 (22%) | 0.96 |
Size > 20 mm | 91 (23%) | 63 (33%) | 0.02 |
> 2 ulcers | 167 (43%) | 96 (50%) | 0.12 |
Need for interventional endoscopic procedure | 233 (60%) | 98 (51%) | 0.057 |
Comorbidities | |||
Heart disease | 83 (21%) | 66 (34%) | < 0.001 |
Pulmonary disease | 26 (7%) | 23 (12%) | 0.044 |
Stroke | 18 (5%) | 26 (14%) | < 0.001 |
Diabetes | 82 (21%) | 34 (18%) | 0.41 |
Liver disease | 21 (5%) | 19 (10%) | 0.062 |
Renal disease | 46 (12%) | 18 (9%) | 0.46 |
History of GU | 107 (27%) | 30 (16%) | 0.0023 |
Symptoms | |||
Hematemesis | 94 (24%) | 69 (36%) | 0.0038 |
Black stool | 315 (81%) | 144 (75%) | 0.14 |
Syncope | 15 (4%) | 10 (5%) | 0.59 |
Medications | |||
Anticoagulation | 29 (7%) | 23 (12%) | 0.099 |
Antiplatelet | 74 (19%) | 73 (38%) | < 0.001 |
NSAIDS | 61 (16%) | 43 (22%) | 0.059 |
COX-2 inhibitor | 3 (1%) | 4 (2%) | 0.23 |
Corticosteroids | 14 (4%) | 7 (4%) | 1 |
PPI | 42 (11%) | 24 (13%) | 0.63 |
H2RA | 24 (6%) | 14 (7%) | 0.73 |